Standout Papers

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice 1994 2026 2004 2015 828
  1. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice (1994)
    Timothy C. Wang, Robert D. Cardiff et al. Nature
  2. Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial (2019)
    Vicky Makker, Drew Rasco et al. The Lancet Oncology
  3. Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer (2020)
    Vicky Makker, Matthew H. Taylor et al. Journal of Clinical Oncology

Immediate Impact

5 by Nobel laureates 24 from Science/Nature 96 standout
Sub-graph 1 of 19

Citing Papers

CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
21 intermediate papers

Works of Emmett V. Schmidt being referenced

Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
2018
Keynote-200 phase 1b: A novel combination study of intravenously delivered coxsackievirus A21 and pembrolizumab in advanced cancer patients.
2017
and 7 more

Author Peers

Author Last Decade Papers Cites
Emmett V. Schmidt 3678 4533 921 1689 143 9.1k
Ralph Schwall 2634 6053 724 1378 85 10.1k
James H. Resau 3057 5216 1391 1173 186 10.6k
Thomas Bugge 1874 4444 807 1597 165 11.1k
Joost J. van den Oord 1895 2732 560 1806 166 7.8k
Massimo Pignatelli 2412 4659 910 753 158 8.4k
Yoichi Furukawa 2243 6432 780 1066 181 9.4k
Onno Kranenburg 2920 5366 594 791 186 9.6k
Pier Giorgio Natali 3082 5216 972 2597 259 11.1k
Yataro Daigo 2983 7715 1532 1554 175 11.2k
Lopa Mishra 2659 3735 807 623 167 7.6k

All Works

Loading papers...

Rankless by CCL
2026